Register for email alerts and news feeds:
This journal | BMJ Group
rss

Receive tables of contents (and more) by e-mail each issue:
Subscribe to Customised @lerts

Advances in targeted therapies: TNFalpha blockade in clinical practice

Contents: November 1999, Volume 58, Supplement 1 [Index by Author]


Table of Contents (PDF)

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstracts' button. To see one abstract at a time, click its [Abstract] link.

Preface: Back

Advances in targeted therapies: TNFalpha blockade in clinical practice
F C BREEDVELD, J R KALDEN, and J S SMOLEN
Ann Rheum Dis 1999; 58 (Supplement 1 ): i1. doi:10.1136/ard.58.2008.i1

Consensus statement: Back

Access to disease modifying treatments for rheumatoid arthritis patients
D E FURST, F C BREEDVELD, G-R BURMESTER, L CROFFORD, P EMERY, M FELDMAN, J R KALDEN, A KAVANAUGH, E KEYSTONE, P E LIPSKY, R N MAINI, L MORELAND, J S SMOLEN, L VAN DE PUTTE, T VISCHER, M WEINBLATT, and M WEISSMAN
Ann Rheum Dis 1999; 58 (Supplement 1 ): i129-i130. doi:10.1136/ard.58.2008.i129

Articles: Back

Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors
Bryant G Darnay and Bharat B Aggarwal
Ann Rheum Dis 1999; 58 (Supplement 1 ): i2-i13. doi:10.1136/ard.58.2008.i2
DAP kinase and DAP-3: novel positive mediators of apoptosis
Adi Kimchi
Ann Rheum Dis 1999; 58 (Supplement 1 ): i14-i19. doi:10.1136/ard.58.2008.i14
Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis
Cornelis L Verweij
Ann Rheum Dis 1999; 58 (Supplement 1 ): i20-i26. doi:10.1136/ard.58.2008.i20
Marc Feldmann, Jan Bondeson, Fionula M Brennan, Brian M J Foxwell, and Ravinder N Maini
Ann Rheum Dis 1999; 58 (Supplement 1 ): i27-i31. doi:10.1136/ard.58.2008.i27
George Kollias, Eleni Douni, George Kassiotis, and Dimitris Kontoyiannis
Ann Rheum Dis 1999; 58 (Supplement 1 ): i32-i39. doi:10.1136/ard.58.2008.i32
Wim B van den Berg, Leo A B Joosten, George Kollias, and Fons A J van de Loo
Ann Rheum Dis 1999; 58 (Supplement 1 ): i40-i48. doi:10.1136/ard.58.2008.i40
Tumour necrosis factor and other cytokines in murine lupus
Argyrios N Theofilopoulos and Brian R Lawson
Ann Rheum Dis 1999; 58 (Supplement 1 ): i49-i55. doi:10.1136/ard.58.2008.i49
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
R N Maini, P C Taylor, E Paleolog, P Charles, S Ballara, F M Brennan, and M Feldmann
Ann Rheum Dis 1999; 58 (Supplement 1 ): i56-i60. doi:10.1136/ard.58.2008.i56
Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment
Gregory Harriman, Lesley K Harper, and Thomas F Schaible
Ann Rheum Dis 1999; 58 (Supplement 1 ): i61-i64. doi:10.1136/ard.58.2008.i61
Leslie Garrison and Neil D McDonnell
Ann Rheum Dis 1999; 58 (Supplement 1 ): i65-i69. doi:10.1136/ard.58.2008.i65
Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7
Joachim Kempeni
Ann Rheum Dis 1999; 58 (Supplement 1 ): i70-i72. doi:10.1136/ard.58.2008.i70
Carl K Edwards, III
Ann Rheum Dis 1999; 58 (Supplement 1 ): i73-i81. doi:10.1136/ard.58.2008.i73
C Bombardier and A Maetzel
Ann Rheum Dis 1999; 58 (Supplement 1 ): i82-i85. doi:10.1136/ard.58.2008.i82
Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis
James F Fries
Ann Rheum Dis 1999; 58 (Supplement 1 ): i86-i89. doi:10.1136/ard.58.2008.i86
FDA perspective on anti-TNF treatments
William D Schwieterman
Ann Rheum Dis 1999; 58 (Supplement 1 ): i90-i91. doi:10.1136/ard.58.2008.i90
European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritis
Gottfried Kreutz
Ann Rheum Dis 1999; 58 (Supplement 1 ): i92-i95. doi:10.1136/ard.58.2008.i92
Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist
Barry Bresnihan
Ann Rheum Dis 1999; 58 (Supplement 1 ): i96-i98. doi:10.1136/ard.58.2008.i96
Interleukin 10 treatment for rheumatoid arthritis
E William St Clair
Ann Rheum Dis 1999; 58 (Supplement 1 ): i99-i102. doi:10.1136/ard.58.2008.i99
Clinical implications of tumour necrosis factor alpha  antagonism in patients with congestive heart failure
Guillermo Torre-Amione, Sonny S Stetson, and John A Farmer
Ann Rheum Dis 1999; 58 (Supplement 1 ): i103-i106. doi:10.1136/ard.58.2008.i103
Immunomodulation by thalidomide and thalidomide analogues
Laura G Corral and Gilla Kaplan
Ann Rheum Dis 1999; 58 (Supplement 1 ): i107-i113. doi:10.1136/ard.58.2008.i107
Anti-TNF antibody treatment of Crohn's disease
S J H van Deventer
Ann Rheum Dis 1999; 58 (Supplement 1 ): i114-i120. doi:10.1136/ard.58.2008.i114
The role of TNFalpha and lymphotoxin in demyelinating disease
Christopher Lock, Jorge Oksenberg, and Lawrence Steinman
Ann Rheum Dis 1999; 58 (Supplement 1 ): i121-i128. doi:10.1136/ard.58.2008.i121
To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstracts' button. To see one abstract at a time, click its [Abstract] link.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs